Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 DKK)

Closing information 2022/12 2021/12 2020/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 1 More Arrow 1,352 Less Arrow 373
Earnings before taxes -27,214 Less Arrow -37,914 More Arrow -32,789
EBITDA -27,213 Less Arrow -37,253 More Arrow -32,416
Total assets 24,510 More Arrow 38,382 Less Arrow 18,646
Current assets 22,486 More Arrow 36,878 Less Arrow 16,970
Current liabilities 4,361 More Arrow 4,406 Less Arrow 3,350
Equity capital 20,149 More Arrow 33,977 Less Arrow 15,296
- share capital 1,709 More Arrow 19,958 Less Arrow 13,106
Employees (average) 5 Equal arrow 5 Less Arrow 4

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 82.2% More Arrow 88.5% Less Arrow 82.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -111.0% More Arrow -95.3% Less Arrow -173.8%
Current ratio 515.6% More Arrow 837.0% Less Arrow 506.6%
Return on equity (ROE) -135.1% More Arrow -111.6% Less Arrow -214.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 25% Less Arrow 0%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.